APP and Alzheimer disease: In conclusion, we show increased levels of HDAC2 and HDAC3 in PBMCs from MCI individuals, AD human brain cortex (Braak staging III–IV) as well as in the hippocampus of APP/PS1 mice and AβO‐treated mouse hippocampal cell line.